BioCentury | Jul 16, 2014
Financial News

RestorGenex raises $35.6 million

...agent. RestorGenex was formed earlier this year through the merger of Paloma Pharmaceuticals Inc. and VasculoMedics Inc....
BioCentury | Jul 14, 2014
Company News

RestorGenex Corp management update

...and David Sherris to CSO from CSO and president of RestorGenex’s Paloma Pharmaceuticals Inc. and VasculoMedics Inc....
BioCentury | Mar 17, 2014
Company News

Paloma, RestorGenex, VasculoMedics deal

...Stratus Media Group Inc. merged with Paloma and VasculoMedics and subsequently changed its name to RestorGenex...
...close of $4.60 on March 10, the day after it completed the split. RestorGenex said VasculoMedics...
...TORC1 ) and TORC2 that has completed Phase I testing for age-related macular degeneration (AMD). VasculoMedics...
Items per page:
1 - 3 of 3
BioCentury | Jul 16, 2014
Financial News

RestorGenex raises $35.6 million

...agent. RestorGenex was formed earlier this year through the merger of Paloma Pharmaceuticals Inc. and VasculoMedics Inc....
BioCentury | Jul 14, 2014
Company News

RestorGenex Corp management update

...and David Sherris to CSO from CSO and president of RestorGenex’s Paloma Pharmaceuticals Inc. and VasculoMedics Inc....
BioCentury | Mar 17, 2014
Company News

Paloma, RestorGenex, VasculoMedics deal

...Stratus Media Group Inc. merged with Paloma and VasculoMedics and subsequently changed its name to RestorGenex...
...close of $4.60 on March 10, the day after it completed the split. RestorGenex said VasculoMedics...
...TORC1 ) and TORC2 that has completed Phase I testing for age-related macular degeneration (AMD). VasculoMedics...
Items per page:
1 - 3 of 3